Evinature

Evinature is a health care startup based in Israel, founded in 2021. The company's mission is to provide natural, evidence-based supplements and tailored treatment plans for the IBD community. By combining modern and traditional medicine, Evinature aims to offer safe and natural remedies endorsed by the medical community with a focus on global accessibility and affordability.

Evinature's approach emphasizes tailored protocols that cater to individual patient needs and severity of their condition. With a commitment to ongoing research and collaboration with over 20 leading medical centers in the U.S, Evinature continuously refines its products to develop effective neutraceuticals accessible worldwide. The company prioritizes evidence and scientific integrity, exclusively distributing products that have passed the golden standard of clinical trials.

One of Evinature's unique aspects is its engagement with the patient community, considering them a valuable resource in healthcare. With a research database founded on patient experiences, each individual contributes simply by taking the assessment, allowing for constant expansion of research and dissemination of vital news and information.

Despite limited information on investments, Evinature's innovative approach to IBD treatment and its focus on evidence-based, tailor-made solutions for patients position it as an intriguing prospect for potential venture capital investors looking to support advancements in healthcare and medical research.